Disclosures for "Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy"
-
Ms. Liu has nothing to disclose.
-
Dr. Krause has nothing to disclose.
-
Dr. Badihian has nothing to disclose.
-
Mr. Harmsen has nothing to disclose.
-
Dr. Jackson has nothing to disclose.
-
Mariana Suarez has nothing to disclose.
-
Dr. Benarroch has nothing to disclose.
-
Dr. Sandroni has nothing to disclose.
-
Dr. Low has nothing to disclose.
-
Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UniQure. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Coon has nothing to disclose.